Condition (MeSH)
Pityriasis
ClinicalTrials.gov lists 10 trials for Pityriasis or a narrower condition beneath it. Jinnah Postgraduate Medical Centre has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
When did Pityriasis trials start? (7)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 1 |
| 2020 | 1 |
| 2019 | 3 |
| 2018 | 2 |
| 2008 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pityriasis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 4 | 2 |
| Not applicable | 2 |
| Observational | 2 |
How many Pityriasis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Completed | 5 |
| Terminated | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pityriasis trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Jinnah Postgraduate Medical Centre | 1 |
Which drugs are being tested for Pityriasis? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Alefacept | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Azithromycin | 1 |
| Bimekizumab regimen 2 iv | 1 |
| Ixekizumab Auto-Injector | 1 |
| Guselkumab Dose 4 | 1 |
| Secukinmab | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Pityriasis trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cholecystitis leading to myocardial infarction and death | 1 | 1 |
Which publications cover Pityriasis? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Pityriasis alba: Possible associations with intestinal helminths and pathogenic protozoa. | International journal of clinical practice | 2020 | Yes |
| Pityriasis Alba--Common Disease, Enigmatic Entity: Up-to-Date Review of the Literature. | Pediatric dermatology | 2015 | Yes |
| A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. | Acta dermato-venereologica | 2013 | Yes |
| Clinical importance of Demodex folliculorum in patients receiving phototherapy. | International journal of dermatology | 2008 | No |
Sub-conditions in MeSH (3)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.